HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.

AbstractOBJECTIVES:
The purpose of this study was to assess the association between B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and the incidence of specific cardiovascular events in low-risk patients with stable coronary disease, the incremental prognostic information obtained from these two biomarkers compared with traditional risk factors, and their ability to identify patients who may benefit from angiotensin-converting enzyme (ACE) inhibition.
BACKGROUND:
The prognostic value of BNPs in low-risk patients with stable coronary artery disease remains unclear.
METHODS:
Baseline plasma BNP and NT-proBNP concentrations were measured in 3,761 patients with stable coronary artery disease and preserved left ventricular function participating in the PEACE (Prevention of Events With Angiotensin-Converting Enzyme Inhibition) study, a placebo-controlled trial of trandolapril. Multivariable Cox regression was used to assess the association between natriuretic peptide concentrations and the incidence of cardiovascular mortality, fatal or nonfatal myocardial infarction, heart failure, and stroke.
RESULTS:
The BNP and NT-proBNP levels were strongly related to the incidence of cardiovascular mortality, heart failure, and stroke but not to myocardial infarction. In multivariable models, BNP remained associated with increased risk of heart failure, whereas NT-proBNP remained associated with increased risk of cardiovascular mortality, heart failure, and stroke. By C-statistic calculations, BNP and NT-proBNP significantly improved the predictive accuracy of the best available model for incident heart failure, and NT-proBNP also improved the model for cardiovascular death. The magnitude of effect of ACE inhibition on the likelihood of experiencing cardiovascular end points was similar, regardless of either BNP or NT-proBNP baseline concentrations.
CONCLUSIONS:
In low-risk patients with stable coronary artery disease and preserved ventricular function, BNPs provide strong and incremental prognostic information to traditional risk factors.
AuthorsTorbjørn Omland, Marc S Sabatine, Kathleen A Jablonski, Madeline Murguia Rice, Judith Hsia, Ragnhild Wergeland, Sverre Landaas, Jean L Rouleau, Michael J Domanski, Christian Hall, Marc A Pfeffer, Eugene Braunwald, PEACE Investigators
JournalJournal of the American College of Cardiology (J Am Coll Cardiol) Vol. 50 Issue 3 Pg. 205-14 (Jul 17 2007) ISSN: 1558-3597 [Electronic] United States
PMID17631211 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Biomarkers
  • Indoles
  • Natriuretic Peptide, Brain
  • trandolapril
Topics
  • Aged
  • Analysis of Variance
  • Angiotensin-Converting Enzyme Inhibitors (administration & dosage)
  • Biomarkers (blood)
  • Chi-Square Distribution
  • Coronary Angiography
  • Coronary Artery Disease (blood, drug therapy, mortality)
  • Humans
  • Indoles (therapeutic use)
  • Middle Aged
  • Multivariate Analysis
  • Natriuretic Peptide, Brain (blood)
  • Probability
  • Prognosis
  • Proportional Hazards Models
  • Risk Assessment
  • Severity of Illness Index
  • Survival Analysis
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: